Yongrui Bao

liaoning university of traditional chinese medicine

H指数:22

被引数:1,186

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An integrated research strategy based on "compound exogenous chemical substances-endogenous metabolites in disease": To explore the scientific basis of Modified Bazhen Yimu Gao in the treatment of primary dysmenorrhea

基于“疾病状态下外源性化学物质-内源性代谢物”的整合研究策略：探索加味八珍益母膏治疗原发性痛经的科学基础

Journal of Ethnopharmacology

IF5.4

2025-08-250

PRE

Identification and validation of the VEGF/p38MAPK/HSP27 pro-tumor inflammatory pathway: screening of active components from Patrinia villosa and evaluation of their drug-likeness

VEGF/p38MAPK/HSP27促肿瘤炎症通路的鉴定与验证：从败酱草中筛选活性成分并评估其成药性

Frontiers in Immunology

IF5.9

2025-08-140

PRE

Dual-Pronged Strike: Curcumin Hijacks FRET Amplification and HSP-70 Sabotage in an NIR Phototheranostic Nanoplatform for Glioblastoma

双刃剑策略：姜黄素劫持FRET放大和HSP-70破坏的近红外光诊疗一体化纳米平台用于胶质母细胞瘤

Journal of Medicinal Chemistry

IF6.8

2025-06-260

PRE

The pathogenesis of hepatocellular carcinoma: ERK/ULK1/ NCOA4-mediated inhibition of iron autophagy, and Epimedium extract targeted modulation of this pathway to treat hepatocellular carcinoma

肝细胞癌的发病机制：ERK/ULK1/NCOA4介导的铁自噬抑制，以及淫羊藿提取物靶向调控该通路以治疗肝细胞癌

PHYTOMEDICINE

IF8.3

2025-06-010

PRE

Integrating metabolomics and network pharmacology to investigate Mu Jin Powder prevents ethanol-induced gastric ulcer in rats

整合代谢组学和网络药理学探讨Mu Jin Powder预防乙醇诱导的大鼠胃溃疡

JOURNAL OF ETHNOPHARMACOLOGY

IF5.4

2025-05-010

PRE

Exploring the transformation of chemical components and the discovery of anti-tumor active components in the fruit of Sinopodophyllum hexandrum

FRONTIERS IN NUTRITION

IF5.1

2025-03-310

OAAI

RETRACTION: Retraction Note: Effect of Oroxylum indicum on hepatocellular carcinoma via the P53 and VEGF pathways based on microfluidic chips

BMC COMPLEMENTARY MEDICINE AND THERAPIES

IF3.4

2025-01-250

OAAI

Enhancing inhibitory effect in SMMC-7721 hepatoma cells through combined treatment of gallic acid and hUC-MSCs-Exos

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2025-01-010

PRE

Metabolomics research on treatment of primary liver cancer with Cortex Juglandis Mandshuricae on LC-MS/MS technology

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2024-09-010

PRE

Sophora japonica Extract Inhibits Ulcerative Colitis and Colitis-Associated Colon Cancer via Regulation of Lipid Metabolism

JOURNAL OF FOOD BIOCHEMISTRY

IF4.2

2024-03-192

RETRACTED: Effect of Oroxylum indicum on hepatocellular carcinoma via the P53 and VEGF pathways based on microfluidic chips (Retracted article. See vol. 25, 2025)

BMC COMPLEMENTARY MEDICINE AND THERAPIES

IF3.4

2023-11-073

Fructus Aurantii Extracts Ameliorate Intestinal Inflammation and Regulate the Intestinal Barrier through Fc Epsilon RI Signaling Pathway

JOURNAL OF FOOD BIOCHEMISTRY

IF4.2

2023-03-201

Multi-omics analysis reveals the mechanisms of action and therapeutic regimens of traditional Chinese medicine, Bufei Jianpi granules: Implication for COPD drug discovery

PHYTOMEDICINE

IF8.3

2022-04-018

PRE

Triterpenoids from Liquidambar Fructus induced cell apoptosis via a PI3K-AKT related signal pathway in SMMC7721 cancer cells

PHYTOCHEMISTRY

IF3.4

2020-03-0117

PREAI

The Pharmacological Effects of Spatholobi Caulis Tannin in Cervical Cancer and Its Precise Therapeutic Effect on Related circRNA

MOLECULAR THERAPY-ONCOLYTICS

IF0

2019-09-0116

OAAI

A multifunctional integrated simultaneously online screening microfluidic biochip for the examination of efficacy-toxicity and compatibility of medicine

CHINESE CHEMICAL LETTERS

IF8.9

2019-02-0116

PREAI

3D microfluidic in vitro model and bioinformatics integration to study the effects of Spatholobi Caulis tannin in cervical cancer

SCIENTIFIC REPORTS

IF3.9

2018-08-1620

OAAI

VPS34 stimulation of p62 phosphorylation for cancer progression

ONCOGENE

IF7.3

2017-08-2857

OAAI

Yongrui Bao

个人简介

教育背景

工作经历

荣誉奖项

研究方向